External validation is often recommended to ensure the generalizability of ML models. However, it neither guarantees generalizability nor equates to a model's clinical usefulness (the ultimate goal of any clinical decision-support tool). External validation is misaligned with current healthcare ML needs. First, patient data changes across time, geography, and facilities. These changes create significant volatility in the performance of a single fixed model (especially for deep learning models, which dominate clinical ML). Second, newer ML techniques, current market forces, and updated regulatory frameworks are enabling frequent updating and monitoring of individual deployed model instances. We submit that external validation is insufficient to establish ML models' safety or utility. Proposals to fix the external validation paradigm do not go far enough. Continued reliance on it as the ultimate test is likely to lead us astray. We propose the MLOps-inspired paradigm of recurring local validation as an alternative that ensures the validity of models while protecting against performance-disruptive data variability. This paradigm relies on site-specific reliability tests before every deployment, followed by regular and recurrent checks throughout the life cycle of the deployed algorithm. Initial and recurrent reliability tests protect against performance-disruptive distribution shifts, and concept drifts that jeopardize patient safety.
Electronic Health Records (EHRs) contain sensitive patient information, which presents privacy concerns when sharing such data. Synthetic data generation is a promising solution to mitigate these risks, often relying on deep generative models such as Generative Adversarial Networks (GANs). However, recent studies have shown that diffusion models offer several advantages over GANs, such as generation of more realistic synthetic data and stable training in generating data modalities, including image, text, and sound. In this work, we investigate the potential of diffusion models for generating realistic mixed-type tabular EHRs, comparing TabDDPM model with existing methods on four datasets in terms of data quality, utility, privacy, and augmentation. Our experiments demonstrate that TabDDPM outperforms the state-of-the-art models across all evaluation metrics, except for privacy, which confirms the trade-off between privacy and utility.
Observational studies have recently received significant attention from the machine learning community due to the increasingly available non-experimental observational data and the limitations of the experimental studies, such as considerable cost, impracticality, small and less representative sample sizes, etc. In observational studies, de-confounding is a fundamental problem of individualised treatment effects (ITE) estimation. This paper proposes disentangled representations with adversarial training to selectively balance the confounders in the binary treatment setting for the ITE estimation. The adversarial training of treatment policy selectively encourages treatment-agnostic balanced representations for the confounders and helps to estimate the ITE in the observational studies via counterfactual inference. Empirical results on synthetic and real-world datasets, with varying degrees of confounding, prove that our proposed approach improves the state-of-the-art methods in achieving lower error in the ITE estimation.
Electronic Health Records (EHRs) are a valuable asset to facilitate clinical research and point of care applications; however, many challenges such as data privacy concerns impede its optimal utilization. Generative Adversarial Networks (GANs) show great promise in generating synthetic EHR data by learning underlying data distributions while achieving excellent performance and addressing these challenges. This work aims to review the major developments in various applications of GANs for EHRs and provides an overview of the proposed methodologies. For this purpose, we combine perspectives from healthcare applications and machine learning techniques in terms of source datasets and the fidelity and privacy evaluation of the generated synthetic datasets. We also compile a list of the metrics and datasets used by the reviewed works, which can be utilized as benchmarks for future research in the field. We conclude by discussing challenges in GANs for EHRs development and proposing recommended practices. We hope that this work motivates novel research development directions in the intersection of healthcare and machine learning.
The recent availability of electronic health records (EHRs) have provided enormous opportunities to develop artificial intelligence (AI) algorithms. However, patient privacy has become a major concern that limits data sharing across hospital settings and subsequently hinders the advances in AI. \textit{Synthetic data}, which benefits from the development and proliferation of generative models, has served as a promising substitute for real patient EHR data. However, the current generative models are limited as they only generate \textit{single type} of clinical data, i.e., either continuous-valued or discrete-valued. In this paper, we propose a generative adversarial network (GAN) entitled EHR-M-GAN which synthesizes \textit{mixed-type} timeseries EHR data. EHR-M-GAN is capable of capturing the multidimensional, heterogeneous, and correlated temporal dynamics in patient trajectories. We have validated EHR-M-GAN on three publicly-available intensive care unit databases with records from a total of 141,488 unique patients, and performed privacy risk evaluation of the proposed model. EHR-M-GAN has demonstrated its superiority in performance over state-of-the-art benchmarks for synthesizing clinical timeseries with high fidelity. Notably, prediction models for outcomes of intensive care performed significantly better when training data was augmented with the addition of EHR-M-GAN-generated timeseries. EHR-M-GAN may have use in developing AI algorithms in resource-limited settings, lowering the barrier for data acquisition while preserving patient privacy.
Given the abundance and ease of access of personal data today, individual privacy has become of paramount importance, particularly in the healthcare domain. In this work, we aim to utilise patient data extracted from multiple hospital data centres to train a machine learning model without sacrificing patient privacy. We develop a scheduling algorithm in conjunction with a student-teacher algorithm that is deployed in a federated manner. This allows a central model to learn from batches of data at each federal node. The teacher acts between data centres to update the main task (student) algorithm using the data that is stored in the various data centres. We show that the scheduler, trained using meta-gradients, can effectively organise training and as a result train a machine learning model on a diverse dataset without needing explicit access to the patient data. We achieve state-of-the-art performance and show how our method overcomes some of the problems faced in the federated learning such as node poisoning. We further show how the scheduler can be used as a mechanism for transfer learning, allowing different teachers to work together in training a student for state-of-the-art performance.
Myocardial Infarction (MI) has the highest mortality of all cardiovascular diseases (CVDs). Detection of MI and information regarding its occurrence-time in particular, would enable timely interventions that may improve patient outcomes, thereby reducing the global rise in CVD deaths. Electrocardiogram (ECG) recordings are currently used to screen MI patients. However, manual inspection of ECGs is time-consuming and prone to subjective bias. Machine learning methods have been adopted for automated ECG diagnosis, but most approaches require extraction of ECG beats or consider leads independently of one another. We propose an end-to-end deep learning approach, DeepMI, to classify MI from normal cases as well as identifying the time-occurrence of MI (defined as acute, recent and old), using a collection of fusion strategies on 12 ECG leads at data-, feature-, and decision-level. In order to minimise computational overhead, we employ transfer learning using existing computer vision networks. Moreover, we use recurrent neural networks to encode the longitudinal information inherent in ECGs. We validated DeepMI on a dataset collected from 17,381 patients, in which over 323,000 samples were extracted per ECG lead. We were able to classify normal cases as well as acute, recent and old onset cases of MI, with AUROCs of 96.7%, 82.9%, 68.6% and 73.8%, respectively. We have demonstrated a multi-lead fusion approach to detect the presence and occurrence-time of MI. Our end-to-end framework provides flexibility for different levels of multi-lead ECG fusion and performs feature extraction via transfer learning.
Cardiac signals, such as the electrocardiogram, convey a significant amount of information about the health status of a patient which is typically summarized by a clinician in the form of a clinical report, a cumbersome process that is prone to errors. To streamline this routine process, we propose a deep neural network capable of captioning cardiac signals; it receives a cardiac signal as input and generates a clinical report as output. We extend this further to generate multilingual reports. To that end, we create and make publicly available a multilingual clinical report dataset. In the absence of sufficient labelled data, deep neural networks can benefit from a warm-start, or pre-training, procedure in which parameters are first learned in an arbitrary task. We propose such a task in the form of discriminative multilingual pre-training where tokens from clinical reports are randomly replaced with those from other languages and the network is tasked with predicting the language of all tokens. We show that our method performs on par with state-of-the-art pre-training methods such as MLM, ELECTRA, and MARGE, while simultaneously generating diverse and plausible clinical reports. We also demonstrate that multilingual models can outperform their monolingual counterparts, informally terming this beneficial phenomenon as the blessing of multilinguality.
The ongoing digitization of health records within the healthcare industry results in large-scale datasets. Manually extracting clinically-useful insight from such datasets is non-trivial. However, doing so at scale while simultaneously leveraging patient-specific attributes such as sex and age can assist with clinical-trial enrollment, medical school educational endeavours, and the evaluation of the fairness of neural networks. To facilitate the reliable extraction of clinical information, we propose to learn embeddings, known as clinical prototypes (CPs), via supervised contrastive learning. We show that CPs can be efficiently used for large-scale retrieval and clustering of physiological signals based on multiple patient attributes. We also show that CPs capture attribute-specific semantic relationships.
Many clinical deep learning algorithms are population-based and difficult to interpret. Such properties limit their clinical utility as population-based findings may not generalize to individual patients and physicians are reluctant to incorporate opaque models into their clinical workflow. To overcome these obstacles, we propose to learn patient-specific embeddings, entitled patient cardiac prototypes (PCPs), that efficiently summarize the cardiac state of the patient. To do so, we attract representations of multiple cardiac signals from the same patient to the corresponding PCP via supervised contrastive learning. We show that the utility of PCPs is multifold. First, they allow for the discovery of similar patients both within and across datasets. Second, such similarity can be leveraged in conjunction with a hypernetwork to generate patient-specific parameters, and in turn, patient-specific diagnoses. Third, we find that PCPs act as a compact substitute for the original dataset, allowing for dataset distillation.